S100A11 and adenoma: Calgizzarin was also studied in colorectal neoplasia: Melle et al. used peptide fingerprint mapping and immunohistochemistry: they confirmed a different expression of S100A11 in the normal colonic epithelium, adenoma and colorectal carcinoma [50].